{"id":13986,"date":"2016-08-15T22:28:47","date_gmt":"2016-08-16T02:28:47","guid":{"rendered":"http:\/\/goldstocksforex.com\/?p=13986"},"modified":"2016-08-15T22:28:47","modified_gmt":"2016-08-16T02:28:47","slug":"defensive-pe-at-a-dangerous-high","status":"publish","type":"post","link":"https:\/\/thepatientinvestor.com\/index.php\/2016\/08\/15\/defensive-pe-at-a-dangerous-high\/","title":{"rendered":"Defensive PE at a dangerous high"},"content":{"rendered":"
\n

Compare the fwd PE of "defensives" today vs. 1999. Doesn't look like exuberance. pic.twitter.com\/W3Q5ZOxWB0<\/a><\/p>\n

— Joe Weisenthal (@TheStalwart) August 14, 2016<\/a><\/p><\/blockquote>\n

Low interest rates and the accompanying search for yield have driven the forward Price-Earnings ratio for Defensives to a 20-year high. This is likely to reverse when (not if) rates eventually rise. Cyclicals and Growth, however, still look reasonable.<\/p>\n","protected":false},"excerpt":{"rendered":"

Compare the fwd PE of "defensives" today vs. 1999. Doesn't look like exuberance. pic.twitter.com\/W3Q5ZOxWB0 — Joe Weisenthal (@TheStalwart) August 14, 2016 Low interest rates and the accompanying search for yield have driven the forward Price-Earnings ratio for Defensives to a 20-year high. This is likely to reverse when (not if) rates eventually rise. Cyclicals and … <\/p>\n

Continue reading “Defensive PE at a dangerous high”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[48,57,34],"tags":[985,2750],"class_list":["post-13986","post","type-post","status-publish","format-standard","hentry","category-earnings-dividends","category-stock-markets","category-us-canada-countries-regions","tag-defensive-stocks","tag-price-earnings-ratio"],"yoast_head":"\nDefensive PE at a dangerous high - the patient investor<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Defensive PE at a dangerous high - the patient investor\" \/>\n<meta property=\"og:description\" content=\"Compare the fwd PE of "defensives" today vs. 1999. Doesn't look like exuberance. pic.twitter.com\/W3Q5ZOxWB0 — Joe Weisenthal (@TheStalwart) August 14, 2016 Low interest rates and the accompanying search for yield have driven the forward Price-Earnings ratio for Defensives to a 20-year high. This is likely to reverse when (not if) rates eventually rise. Cyclicals and … Continue reading "Defensive PE at a dangerous high"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thepatientinvestor.com\/index.php\/2016\/08\/15\/defensive-pe-at-a-dangerous-high\/\" \/>\n<meta property=\"og:site_name\" content=\"the patient investor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\" \/>\n<meta property=\"article:published_time\" content=\"2016-08-16T02:28:47+00:00\" \/>\n<meta name=\"author\" content=\"ColinTwiggs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ColinTwiggs\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/08\/15\/defensive-pe-at-a-dangerous-high\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/08\/15\/defensive-pe-at-a-dangerous-high\/\"},\"author\":{\"name\":\"ColinTwiggs\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5\"},\"headline\":\"Defensive PE at a dangerous high\",\"datePublished\":\"2016-08-16T02:28:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/08\/15\/defensive-pe-at-a-dangerous-high\/\"},\"wordCount\":71,\"commentCount\":1,\"publisher\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\"},\"keywords\":[\"Defensive stocks\",\"price-earnings ratio\"],\"articleSection\":[\"Earnings & Dividends\",\"Stock Markets\",\"US & Canada\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/thepatientinvestor.com\/index.php\/2016\/08\/15\/defensive-pe-at-a-dangerous-high\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/08\/15\/defensive-pe-at-a-dangerous-high\/\",\"url\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/08\/15\/defensive-pe-at-a-dangerous-high\/\",\"name\":\"Defensive PE at a dangerous high - the patient investor\",\"isPartOf\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#website\"},\"datePublished\":\"2016-08-16T02:28:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/08\/15\/defensive-pe-at-a-dangerous-high\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/thepatientinvestor.com\/index.php\/2016\/08\/15\/defensive-pe-at-a-dangerous-high\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/08\/15\/defensive-pe-at-a-dangerous-high\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/thepatientinvestor.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Defensive PE at a dangerous high\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/thepatientinvestor.com\/#website\",\"url\":\"https:\/\/thepatientinvestor.com\/\",\"name\":\"The Patient Investor\",\"description\":\"Smart. Strategic. Unfiltered. \",\"publisher\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/thepatientinvestor.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\",\"name\":\"The Patient Investor Pty Ltd\",\"url\":\"https:\/\/thepatientinvestor.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"width\":250,\"height\":250,\"caption\":\"The Patient Investor Pty Ltd\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\",\"https:\/\/www.instagram.com\/colin_thepatientinvestor\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5\",\"name\":\"ColinTwiggs\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"caption\":\"ColinTwiggs\"},\"url\":\"https:\/\/thepatientinvestor.com\/index.php\/author\/colin58s\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Defensive PE at a dangerous high - the patient investor","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"Defensive PE at a dangerous high - the patient investor","og_description":"Compare the fwd PE of "defensives" today vs. 1999. Doesn't look like exuberance. pic.twitter.com\/W3Q5ZOxWB0 — Joe Weisenthal (@TheStalwart) August 14, 2016 Low interest rates and the accompanying search for yield have driven the forward Price-Earnings ratio for Defensives to a 20-year high. This is likely to reverse when (not if) rates eventually rise. Cyclicals and … Continue reading \"Defensive PE at a dangerous high\"","og_url":"https:\/\/thepatientinvestor.com\/index.php\/2016\/08\/15\/defensive-pe-at-a-dangerous-high\/","og_site_name":"the patient investor","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61572934660810","article_published_time":"2016-08-16T02:28:47+00:00","author":"ColinTwiggs","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ColinTwiggs"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/08\/15\/defensive-pe-at-a-dangerous-high\/#article","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/08\/15\/defensive-pe-at-a-dangerous-high\/"},"author":{"name":"ColinTwiggs","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5"},"headline":"Defensive PE at a dangerous high","datePublished":"2016-08-16T02:28:47+00:00","mainEntityOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/08\/15\/defensive-pe-at-a-dangerous-high\/"},"wordCount":71,"commentCount":1,"publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"keywords":["Defensive stocks","price-earnings ratio"],"articleSection":["Earnings & Dividends","Stock Markets","US & Canada"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/thepatientinvestor.com\/index.php\/2016\/08\/15\/defensive-pe-at-a-dangerous-high\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/08\/15\/defensive-pe-at-a-dangerous-high\/","url":"https:\/\/thepatientinvestor.com\/index.php\/2016\/08\/15\/defensive-pe-at-a-dangerous-high\/","name":"Defensive PE at a dangerous high - the patient investor","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/#website"},"datePublished":"2016-08-16T02:28:47+00:00","breadcrumb":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/08\/15\/defensive-pe-at-a-dangerous-high\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thepatientinvestor.com\/index.php\/2016\/08\/15\/defensive-pe-at-a-dangerous-high\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/08\/15\/defensive-pe-at-a-dangerous-high\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thepatientinvestor.com\/"},{"@type":"ListItem","position":2,"name":"Defensive PE at a dangerous high"}]},{"@type":"WebSite","@id":"https:\/\/thepatientinvestor.com\/#website","url":"https:\/\/thepatientinvestor.com\/","name":"The Patient Investor","description":"Smart. Strategic. Unfiltered. ","publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thepatientinvestor.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/thepatientinvestor.com\/#organization","name":"The Patient Investor Pty Ltd","url":"https:\/\/thepatientinvestor.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","width":250,"height":250,"caption":"The Patient Investor Pty Ltd"},"image":{"@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61572934660810","https:\/\/www.instagram.com\/colin_thepatientinvestor"]},{"@type":"Person","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5","name":"ColinTwiggs","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","caption":"ColinTwiggs"},"url":"https:\/\/thepatientinvestor.com\/index.php\/author\/colin58s\/"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p9tQ4n-3DA","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":14767,"url":"https:\/\/thepatientinvestor.com\/index.php\/2017\/02\/04\/sp-500-price-earnings-suggest-time-to-buy\/","url_meta":{"origin":13986,"position":0},"title":"S&P 500 Price-Earnings suggest time to buy","author":"ColinTwiggs","date":"February 4, 2017","format":false,"excerpt":"The forward Price-Earnings (PE) Ratio for the S&P 500, depicted by the blue line on the chart below, recently dipped below 20. In 2014 to 2105, PEs above 20 warned that stocks were overpriced. We can see from the green and orange bars on the chart that the primary reason\u2026","rel":"","context":"In "Earnings & Dividends"","block_context":{"text":"Earnings & Dividends","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/investing\/earnings-dividends\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":17854,"url":"https:\/\/thepatientinvestor.com\/index.php\/2019\/02\/08\/price-earnings-versus-growth\/","url_meta":{"origin":13986,"position":1},"title":"Price-Earnings versus Growth","author":"Colin Twiggs","date":"February 8, 2019","format":false,"excerpt":"A comment at lunch today about high price-earnings multiples got me started on one of my favorite topics: investment returns. Most of us use the basic price-earnings ratio (PE or P\/E) as a rough measure of how highly priced a stock is. The higher the P\/E, the higher the risk.\u2026","rel":"","context":"In "Earnings & Dividends"","block_context":{"text":"Earnings & Dividends","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/investing\/earnings-dividends\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":43986,"url":"https:\/\/thepatientinvestor.com\/index.php\/2023\/09\/08\/overpriced-sp-500-ignores-declining-growth\/","url_meta":{"origin":13986,"position":2},"title":"Overpriced S&P 500 ignores declining growth","author":"Colin Twiggs","date":"September 8, 2023","format":false,"excerpt":"The S&P 500 price-to-sales ratio jumped to 2.44 in June -- way above its long-term average of 1.68. Price-earnings ratio (PE) calculated using highest trailing earnings, surged to 22.5 in June -- well above the peaks from earlier crises like October 1929 (Black Friday) and October 1987 (Black Monday). Robert\u2026","rel":"","context":"In "Banks & Interest Rates"","block_context":{"text":"Banks & Interest Rates","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/economy\/the-fed-banks-interest-rates\/"},"img":{"alt_text":"S&P 500 Price-to-Sales","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2023\/2023-09-07-spx--sales.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2023\/2023-09-07-spx--sales.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2023\/2023-09-07-spx--sales.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2023\/2023-09-07-spx--sales.png?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":9043,"url":"https:\/\/thepatientinvestor.com\/index.php\/2014\/01\/26\/beware-of-the-cape\/","url_meta":{"origin":13986,"position":3},"title":"Beware of the CAPE","author":"ColinTwiggs","date":"January 26, 2014","format":false,"excerpt":"I have just read John Mauldin's warning that the market is overvalued: Not only does today's CAPE of 25.4x suggest a seriously overvalued market, but the rapid multiple expansion of the last few years coupled with sluggish earnings growth suggests that this market is also seriously overbought, as I pointed\u2026","rel":"","context":"In "Stock Markets"","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"CAPE","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2014\/mauldin-cape.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2014\/mauldin-cape.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2014\/mauldin-cape.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2014\/mauldin-cape.png?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":13708,"url":"https:\/\/thepatientinvestor.com\/index.php\/2014\/01\/26\/beware-of-the-cape-2\/","url_meta":{"origin":13986,"position":4},"title":"Beware of the CAPE","author":"ColinTwiggs","date":"January 26, 2014","format":false,"excerpt":"I have just read John Mauldin's warning that the market is overvalued: Not only does today's CAPE of 25.4x suggest a seriously overvalued market, but the rapid multiple expansion of the last few years coupled with sluggish earnings growth suggests that this market is also seriously overbought, as I pointed\u2026","rel":"","context":"In "Market Insights"","block_context":{"text":"Market Insights","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/market-insights\/"},"img":{"alt_text":"CAPE","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2014\/mauldin-cape.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2014\/mauldin-cape.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2014\/mauldin-cape.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2014\/mauldin-cape.png?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":14689,"url":"https:\/\/thepatientinvestor.com\/index.php\/2016\/12\/15\/nasdaq-breaks-its-dotcom-high\/","url_meta":{"origin":13986,"position":5},"title":"Nasdaq breaks its Dotcom high","author":"ColinTwiggs","date":"December 15, 2016","format":false,"excerpt":"Tech-heavy Nasdaq 100 broke through its all-time high at 4900, first reached in the Dotcom bubble of 1999\/2000. Follow-through above 5000 would signal another primary advance. Bearish divergence on 13-week Twiggs Money Flow warns of medium-term selling pressure, possibly profit-taking at the long-term high. The daily chart of the S&P\u2026","rel":"","context":"In "Earnings & Dividends"","block_context":{"text":"Earnings & Dividends","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/investing\/earnings-dividends\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/13986","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/comments?post=13986"}],"version-history":[{"count":0,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/13986\/revisions"}],"wp:attachment":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/media?parent=13986"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/categories?post=13986"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/tags?post=13986"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}